Darlene Noci
Corporate Officer/Principal bij NUVALENT, INC.
Vermogen: 2 M $ op 31-05-2024
Profiel
Darlene Noci is the founder of Noci Strategic Consulting LLC, which was founded in 2018.
Currently, Ms. Noci is the Chief Development Officer at Nuvalent, Inc. since 2022.
Previously, Ms. Noci held the position of Head-Regulatory Affairs at AVEO Pharmaceuticals, Inc. Ms. Noci also served as the VP-Regulatory Affairs & Quality Assurance at X4 Pharmaceuticals, Inc. from 2016 to 2018, and as a Principal at EMD Serono, Inc. from 2014 to 2016.
Ms. Noci obtained a graduate degree from Harvard University and an undergraduate degree from Adelphi University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NUVALENT, INC. CLASS A
0.06% | 22-03-2024 | 33 300 ( 0.06% ) | 2 M $ | 31-05-2024 |
Actieve functies van Darlene Noci
| Bedrijven | Functie | Begin |
|---|---|---|
| NUVALENT, INC. | Corporate Officer/Principal | 20-07-2022 |
Eerdere bekende functies van Darlene Noci
| Bedrijven | Functie | Einde |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Algemeen Adviseur | 01-05-2018 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 01-01-2016 |
| Noci Strategic Consulting LLC | Oprichter | - |
| AVEO PHARMACEUTICALS, INC. | Algemeen Adviseur | - |
Opleiding van Darlene Noci
| Adelphi University | Undergraduate Degree |
| Harvard University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| X4 PHARMACEUTICALS, INC. | Health Technology |
| NUVALENT, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
| Noci Strategic Consulting LLC | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
